Progress in neurosciences: initiatives within the framework of the program "Brain Decade (1990-2000)"

• Published in: Vestnik Rossiĭskoĭ akademii medits︠i︡nskih nauk no. 7; p. 3
• Main Authors: Vereshchagin, N V, Piradov, M A
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 2001
• Subjects: Academies and Institutes; Animals; Biomarkers; Brain Death; Brain Diseases - diagnosis; Brain Diseases - genetics; Brain Diseases - physiopathology; Brain Diseases - therapy; Central Nervous System Diseases - diagnosis; Central Nervous System Diseases - physiopathology; Central Nervous System Diseases - therapy; Cerebral Revascularization; Cerebrovascular Disorders - diagnosis; Cerebrovascular Disorders - physiopathology; Cerebrovascular Disorders - therapy; Humans; Nervous System Diseases - diagnosis; Nervous System Diseases - genetics; Nervous System Diseases - physiopathology; Nervous System Diseases - therapy; Neurosciences - trends; Plasmapheresis; Polyneuropathies - diagnosis; Polyneuropathies - physiopathology; Polyneuropathies - therapy; Prion Diseases - diagnosis; Prion Diseases - physiopathology; Prion Diseases - therapy; Rats; Russia; Russia
• ISSN: 0869-6047

The paper describes basic scientific and practical results obtained in the past decade at the Research Institute of Neurology, Russian Academy of Medical Sciences, in the following areas: cerebrovascular diseases, degenerative and demyelinating diseases of the nervous system. Particular attention is paid to the development of national criteria for brain death, a concept of structural and functional levels of the vascular system, that of brain pathology in atherosclerosis and essential hypertension, rapid methods for evaluating neuronal apoptosis, a new method for diagnosing prionic diseases caused by a classical viruses, and a new method for histochemical diagnosis of the degree of reparative peripheral nerve processes in polyneuropathies and to the discovery of two new hereditary nervous system diseases, to direct DNA diagnosis of torsion dystonia, Wilson-Konovalov disease, Friedreich's disease, to the setting up of a national representative family register and DNA data bank for monogenous hereditary diseases, to the development of indications for craniocerebral bypass of cerebral vessels in multiple occlusions of great cerebral arteries and indications for programmable plasmapheresis in a number of autoimmune diseases of the nervous system, to the development of rehabilitative programmes for stabilogram biocontrol, markers of an active embologenous atherosclerotic plaque in the arteries supplying blood to the brain, etc.